Bausch + Lomb Corporation Files Registration Statement and Preliminary Prospectus for Proposed Initial Public Offering Pharmaceutical Investing
Abbott Receives U.S. FDA Clearance for New Cardiac Mapping System to Improve How Doctors Treat Abnormal Heart Rhythms Pharmaceutical Investing
Positive Top-Line Results of Pfizer's Phase 3 Study Exploring Coadministration of PREVNAR 20 With Pfizer-BioNTech COVID-19 Vaccine in Older Adults Released Life Science Investing
Jamieson Wellness Celebrates a Century of Improving the World's Health and Wellness Life Science Investing
AbbVie Confirms Guidance of Greater Than $15 Billion in Combined Risk-Adjusted Sales for Rinvoq and Skyrizi in 2025 Pharmaceutical Investing
Bausch Health Will Provide Business And Strategic Update At The 40th Annual J.P. Morgan Healthcare Conference Pharmaceutical Investing
BioAtla Announces Clinical Collaboration with Bristol Myers Squibb to Study Mecbotamab Vedotin and Ozuriftamab Vedotin in Combination with Opdivo® for Treatment of Solid Tumors Pharmaceutical Investing
Gilead Announces Clinical Trial Collaborations With Merck to Evaluate Trodelvy® in Combination With KEYTRUDA® in First-Line Metastatic Non-Small Cell Lung Cancer Pharmaceutical Investing
Century Therapeutics and Bristol Myers Squibb Enter into a Strategic Collaboration to Develop iPSC-derived Allogeneic Cell Therapies Pharmaceutical Investing
